Pregnancy Registry for Multiple Sclerosis

French Registry for Monitoring Pregnancies for Multiple Sclerosis

Recruiting Observational Study
Sclerosis, Multiple Neuromyelitis Optica Spectrum Disorder Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders Pregnancy Abnormal
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Hospices Civils de Lyon · Other
Who this trial is looking for

This trial is looking for women with multiple sclerosis who are currently pregnant or planning to become pregnant. Participants will help researchers understand how pregnancy affects multiple sclerosis and the health of both mother and child.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with multiple sclerosis
  • I am currently pregnant or will be before delivery
  • I can understand and read French
  • I can give informed consent
  • I may be under 18 years old if my parents agree
  • I have any type of multiple sclerosis or related conditions

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The influence of pregnancy on the course of multiple sclerosis (MS) has long been a controversial topic. After the publication of the first large prospective study of pregnancy and MS in 1998, counselling of women with MS has radically changed and many patients have been able to fulfill their desire of motherhood. However, there are still some challenges for the neurologist, who has to face old un…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All groups of patients eligible to participate to the Observatoire Français de la Sclérose en Plaque (OFSEP), including : * Definite Multiple sclerosis (MS) according to McDonald criteria * Whatever the clinical course (single attack MS, relapsing-remitting MS, secondary progr…
Contacts

Sandra VUKUSIC, Prof.

4 72 68 13 13

sandra.vukusic@chu-lyon.fr

CONTACT

Romain MARIGNIER, MD

4 72 68 13 13

romain.marignier@chu-lyon.fr

CONTACT